These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 4830656

  • 1. [Certain problems of etiology, pathogenesis, treatment and prophylaxis of eczema in mycoses of the feet].
    Korolev IuF, Khodiukov EIa.
    Vestn Dermatol Venerol; 1974; 48(3):51-5. PubMed ID: 4830656
    [No Abstract] [Full Text] [Related]

  • 2. [Circulating immune complexes in mycoses and eczema of the skin of the feet].
    Iutskovskiĭ AD, Leshchenko GM, Fedotov VP.
    Vestn Dermatol Venerol; 1988; (1):22-6. PubMed ID: 3364015
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Fungi as 1 of the basic causes of eczematous body reactions].
    Iutskovskiĭ AD, Fedotov VP.
    Vestn Dermatol Venerol; 1981 Nov; (11):34-8. PubMed ID: 7314890
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of tolnaftate powder in the treatment and prophylaxis of foot mycoses.
    Balogh E, Nagy E, Mészáros C.
    Ther Hung; 1988 Nov; 36(2):86-7. PubMed ID: 3201392
    [No Abstract] [Full Text] [Related]

  • 10. [Foot mycoses complicated by secondary infection].
    Nemkaeva RM.
    Vestn Dermatol Venerol; 1985 Apr; (4):55-6. PubMed ID: 3159167
    [No Abstract] [Full Text] [Related]

  • 11. [Foot mycoses and our experience in controlling them].
    Belukha UK, Deboĭ LN, Fomina ZN, Kim AN.
    Vestn Dermatol Venerol; 1974 May; 48(4):82-5. PubMed ID: 4275721
    [No Abstract] [Full Text] [Related]

  • 12. [Changes in lymphocyte and neutrophil rosette formation in patients with microbial eczema and tinea pedis].
    Fedotov VP, Tsepkova EA, Diudiun AD.
    Vestn Dermatol Venerol; 1984 Aug; (8):16-9. PubMed ID: 6485532
    [No Abstract] [Full Text] [Related]

  • 13. [Immunoglobulins and protein fractions of blood serum in tinea pedis and eczema].
    Khodiukova AB, Khodiukov EIa, Vedernikova LV.
    Vestn Dermatol Venerol; 1978 Feb; (2):72-5. PubMed ID: 636599
    [No Abstract] [Full Text] [Related]

  • 14. [Allergy in foot mycoses].
    Schulz KH.
    Arch Klin Exp Dermatol; 1966 Feb; 227(1):560-4. PubMed ID: 5984798
    [No Abstract] [Full Text] [Related]

  • 15. [Use of formidron for the treatment and prevention of foot mycoses and perspiration].
    Zuikhin DP, Mansurov RM.
    Voen Med Zh; 1975 Jun; (6):76. PubMed ID: 1189331
    [No Abstract] [Full Text] [Related]

  • 16. [The local therapy of superinfected dermatoses].
    Steppert A.
    Wien Med Wochenschr; 1967 Jul 29; 117(29):725-8. PubMed ID: 4233963
    [No Abstract] [Full Text] [Related]

  • 17. [Studies of mycotic allergy].
    Leshchenko VM, Borodin IuP, Leshchenko GM.
    Vestn Dermatol Venerol; 1975 Oct 29; (10):36-40. PubMed ID: 775841
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The characteristics of the clinical manifestations and the pathogenesis of foot mycoses complicated by candidiasis in metallurgists].
    Mikhasik SV, Fedotov VP, Leshchenko GM.
    Vestn Dermatol Venerol; 1990 Oct 29; (7):45-8. PubMed ID: 2147804
    [Abstract] [Full Text] [Related]

  • 20. [The epidemiological approach to the therapy of foot mycoses].
    Chmel L, Valentová M.
    Z Haut Geschlechtskr; 1969 Sep 15; 44(18):761-4. PubMed ID: 5382944
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.